Arkolith/Funds/Finepoint Capital LP

Finepoint Capital LP

CIK 1608126Hedge fund
Holdings as of Jun 30, 2026·disclosed Aug 13, 2026·~44-day 13F lag·13F-HR
Active Filer

Finepoint Capital LP holds a concentrated book of 6 stocks worth $461.0M as of Q2 2026 (disclosed Aug 13, 2026, a ~44-day 13F lag). This quarter they trimmed Rxo Inc. Their largest long position is Qxo Inc at 68% of the equity book. They also disclosed $1.7B in put options (a bearish bet) and $592.1M in call options (bullish), shown separately below and excluded from the equity book.

Opened
0
bought for the first time
no new positions
Added to
1
already held, bought more
Trimmed
1
sold some, still holds it
Sold out
0
exited the position entirely
nothing exited

Concentration

Top-heavy: concentrated book

Top 5 holdings
100%
Top 10 holdings
100%
Top 20 holdings
100%

Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.

Direct sector allocation

100% mapped to company sectors

Industrials
100%
Energy
0%
Health Care
0%

Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.

Biggest moves: latest quarter

Estimated $ traded · quarter-end prices, no cost basis

Bought
Trimmed / exited

Funds with the most overlap

Other tracked managers holding the same core names as Finepoint Capital LP

Manager / fundShared namesTheir $ in those
MFN Partners Management, LP2 / 6$1.2B
Orbis Allan Gray Ltd2 / 6$2.3B
FRED ALGER MANAGEMENT, LLC2 / 6$442.5M
Hood River Capital Management LLC2 / 6$264.1M
Neo Ivy Capital Management2 / 6$4.8M
Aureus Asset Management, LLC2 / 6$7.4M
FRONTIER CAPITAL MANAGEMENT CO LLC2 / 6$45.8M
DELTEC ASSET MANAGEMENT LLC2 / 6$2.5M

Ranked by the share of each fund's own book sitting in the names it shares with Finepoint Capital LP: only funds sharing at least a tenth of the book qualify. Index giants, bank custody books and market makers are excluded. They hold everything, so their overlap says nothing.

Holdings: largest first

Bars show each stock's share of the portfolio. Click a row for its position history.

6 positions
#SecurityValueShares% PortLast moveHistory
1Qxo Inc
COM NEW
$313.0M18.11M
67.9%
+31%
Added · +4.3M sh
2Rxo Inc
COMMON STOCK
$147.8M5.36M
32.0%
−47%
Reduced · −4.7M sh
3Aleanna Inc
*W EXP 12/13/202
$147K490.0K
0.0%
Held
4Aleanna Inc
COM CL A
$80K27.7K
0.0%
Held
5Moneyhero Limited
*W EXP 09/13/202
$37K895.0K
0.0%
Held
6Calidi Biotherapeutics Inc
COM
$1771.0K
0.0%
Held
Showing all 6 positions
Build

Build on this 13F portfolio

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Build

Ask your agent what Finepoint Capital LP owns

This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/funds/1608126/holdings"
Ask your agent
Use Arkolith to show Finepoint Capital LP's latest
holdings, largest changes, and filing provenance.

Largest options & derivatives disclosed

Put / call positions from the 13F — totals include every disclosed option leg

Put notional (bearish)$1.7B
Call notional (bullish)$592.1M
TypeUnderlyingNotional valueUnderlying shares
PUT · bearishSS SPDR S&P 500 ETF TRUST-USSPY$1.3B1.7M
CALL · bullishMICROSOFT CORPMSFT$592.1M1.6M
PUT · bearishINVESCO QQQ TRUST SERIES 1QQQ$467.4M635K

13F filers disclose option positions at the market value of the underlying the contracts reference, not the premium paid. A put is a bearish bet (it gains if the stock falls); a call is bullish. “Underlying shares” is the share count the contracts control, not a share holding. These legs are excluded from the equity book, weighting, concentration and sector figures above.

Filing history

As-of date vs the date the SEC received each filing

QuarterAs ofFiledPositionsValueForm
Q2 2026Jun 30, 2026Aug 13, 20269$2.8B13F-HR
Q1 2026Mar 31, 2026May 14, 20269$2.0B13F-HR
Q4 2025Dec 31, 2025Feb 13, 20269$2.0B13F-HR
Q3 2025Sep 30, 2025Nov 13, 20259$1.7B13F-HR
Q2 2025Jun 30, 2025Aug 13, 202510$1.4B13F-HR
Q1 2025Mar 31, 2025May 14, 202525$1.3B13F-HR
Q4 2024Dec 31, 2024Feb 13, 202526$1.6B13F-HR
Q3 2024Sep 30, 2024Nov 13, 202426$1.4B13F-HR
Q2 2024Jun 30, 2024Aug 13, 202425$352.3M13F-HR
Q1 2024Mar 31, 2024May 14, 202426$389.9M13F-HR
Q4 2023Dec 31, 2023Feb 13, 202427$317.0M13F-HR
Q3 2023Sep 30, 2023Nov 13, 202330$200.8M13F-HR
Q2 2023Jun 30, 2023Aug 11, 202337$289.1M13F-HR
Q1 2023Mar 31, 2023May 12, 202338$261.8M13F-HR
Q4 2022Dec 31, 2022Feb 13, 202344$309.3M13F-HR
Q3 2022Sep 30, 2022Nov 10, 202257$304.0M13F-HR
Q2 2022Jun 30, 2022Aug 12, 202260$289.2M13F-HR
Q1 2022Mar 31, 2022May 13, 202263$300.8M13F-HR
Q4 2021Dec 31, 2021Feb 11, 202271$390.1M13F-HR
Q3 2021Sep 30, 2021Nov 12, 202174$585.7M13F-HR
Q2 2021Jun 30, 2021Aug 13, 202143$533.4M13F-HR
Q1 2021Mar 31, 2021May 14, 20211$013F-HR
Q4 2020Dec 31, 2020Feb 12, 20211$2.5M13F-HR
Q3 2020Sep 30, 2020Nov 13, 20201$83.1M13F-HR

Data source

Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.